September 12, 2025. MORRISTOWN, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today announced its decision to voluntarily withdraw Ocaliva (obeticholic...
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
